Table 3 Clinical details of children with B19V infection.

From: A cross-sectional study on risk factors for infection with Parvovirus B19 and the association with anaemia in a febrile paediatric population in Ghana

 

No B19V infection (%)

B19V infection (IgM and/or PCR +) (%)

Total

1110 (93.6)

76 (6.4)

Vomiting

437 (39.4)

34 (44.7)

Cough

285 (25.7)

16 (21.1)

Diarrhoea

189 (17.0)

13 (17.1)

Spleen enlargement

98 (8.8)a

10 (13.2)

Respiratory distress

106 (9.6)a

9 (11.8)

Liver enlargement

76 (6.9)a

7 (9.2)

Abdominal pain

56 (5.1)

4 (5.3)

Generalized lymphadenopathy

3 (0.3)a

2 (2.7)a

Rash

24 (2.2)a

2 (2.6)

Neurological symptoms

32 (2.9)

0

Body temperature (°C)

Median (IQR)

39 (38.5–39.6)

39.3 (38.7–39.8)

Duration of admission (days)

Median (IQR)

2 (2–4)

2 (1–3)

Anaemiab

Severe

131 (11.8)

8 (10.5)

Moderate

419 (37.8)

40 (52.6)

Mild

195 (17.6)

10 (13.2)

No anaemia

364 (32.8)

17 (22.4)

  1. aMissing data (No B19V infection: spleen enlargement n = 12, resp. distress n = 9, liver enlargement n = 11, gen. lymphadenopathy n = 5, rash n = 1; B19V infection: gen. lymphadenopathy n = 1).
  2. bHb-value available for 1184 cases.
Back to article page